CRNX Stock Analysis: Buy, Sell, or Hold?
CRNX - Crinetics Pharmaceuticals, Inc.
$34.99
-1.19 (-3.29%)
▼
5d:
-2.13%
30d:
-4.87%
90d:
-3.71%
BUY
HIGH Confidence
Analysis Updated: Jun 25, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When CRNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CRNX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CRNX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CRNX is currently trading at $34.99, which is considered fair relative to its 30-day fair value range of $33.88 to $36.31.
Technical Outlook: Technically, CRNX is in a downtrend. Immediate support is located at $32.70, while resistance sits at $37.66. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: CRNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $83.14 (+137.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRNX is in a downtrend. Immediate support is located at $32.70, while resistance sits at $37.66. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: CRNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $83.14 (+137.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$33.88 -
$36.31
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 137.6% below Wall St target ($83.14)
Trading Range Analysis
30-Day Trading Range
$33.88 -
$36.31
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$32.71
Resistance Level
$37.67
Current Trend
Downtrend
Technical data as of
Jun 25, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.31
Wall Street Target
$83.14
(+137.6%)
Revenue Growth (YoY)
2873.4%
Share & Embed Analysis
Last updated: June 25, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRNX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeff E Knight
SELL
85163 shares
2026-04-08
Jeff E Knight
SELL
9911 shares
2026-03-16
Richard Scott Struthers
SELL
21981 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 63 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 53 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 57 HOLD |
